Unicycive Therapeutics, Inc.
UNCY
$0.64
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.73M | -23.00M | -23.24M | -36.93M | -30.54M |
| Total Depreciation and Amortization | 428.00K | 376.00K | 332.00K | 523.00K | 284.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.15M | -2.83M | -2.15M | 13.88M | 12.07M |
| Change in Net Operating Assets | -427.00K | -1.01M | 3.42M | 1.71M | -93.00K |
| Cash from Operations | -28.58M | -26.47M | -21.64M | -20.82M | -18.28M |
| Capital Expenditure | -72.00K | -50.00K | -26.00K | -18.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -72.00K | -50.00K | -26.00K | -18.00K | -12.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 683.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 50.00M | 50.00M | 50.00M | 50.00M | 30.19M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.10M | -1.10M | -1.10M | -- | -- |
| Other Financing Activities | -4.50M | -4.39M | -4.28M | -4.57M | -2.65M |
| Cash from Financing | 45.09M | 44.52M | 44.62M | 45.44M | 27.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.44M | 18.00M | 22.96M | 24.60M | 9.25M |